Gene · 6443
SGCB: sarcoglycan beta
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SGCB: sarcoglycan beta. Genes, record 6443. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6443
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16585 | Beta-sarcoglycan | 318 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents47
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026022658 A | 2026-02-12 | 46 | Q16585 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 62652 | Q16585 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 10459 | Q16585 | Espacenet |
| JP 2025170362 A | 2025-11-18 | 2 | Q16585 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10780 | Q16585 | Espacenet |
| JP 2025139591 A | 2025-09-26 | 2 | Q16585 | Espacenet |
| JP 2025139591 A | 2025-09-26 | 18 | Q16585 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3930 | Q16585 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3930 | Q16585 | Espacenet |
| JP 2025523953 A | 2025-07-25 | 145 | Q16585 | Espacenet |
1 to 10 of 47
See all 47 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants820
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SGCB papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| R01HL098032 | Omics, mice and men: Development of precision transfusion medicine | 3 | 2025 |
| R01NS090634 | Whole body single AAV microgene in canine DMD | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 2 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 2 | 2025 |
| R01AR042423 | Cytoskeletal Interactions of Dystrophin | 2 | 2025 |
| R01CA247992 | Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation | 2 | 2025 |
| R01CA250025 | Molecular mechanisms driving mesenchymal colorectal cancer | 2 | 2025 |
1 to 10 of 820Source NIH's project files
See all 820 nih grantsPapers1,640
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 6-Nitrodopamine as a Novel Mediator of Prostatic Smooth Muscle Function in Mouse and Human. | Andrology | 2026 | 42746669 | PubTator, text mining | PubMed |
| Soluble guanylyl cyclase maturation in cells depends on reduction of the incoming heme by a cysteine in the enzyme's beta subunit. | J Biol Chem | 2026 | 42710661 | PubTator, text mining | PubMed |
| Unraveling the NO-sGC-cGMP pathway in BPD-associated pulmonary hypertension. | Am J Physiol Heart Circ Physiol | 2026 | 42709032 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing in Undiagnosed Muscular Dystrophies: A High Diagnostic Yield and Novel Insights From Iranian Families. | Hum Mutat | 2026 | 42553504 | PubTator, text mining | PubMed |
| The Therapeutic Efficacy of Drugs Targeting the NO-sGC-cGMP Pathway in Treatment of Patients With Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review. | Pulm Circ | 2026 | 42516671 | PubTator, text mining | PubMed |
| Defining Haplosufficiency in Autosomal Recessive Limb-Girdle Muscular Dystrophy Using Molecular Markers in Disease Carriers. | Neurol Genet | 2026 | 42453854 | PubTator, text mining | PubMed |
| Pitfalls of Therapies Targeting the Nitric Oxide Signaling Pathway in Heart Failure With Preserved Ejection Fraction. | J Cardiovasc Pharmacol | 2026 | 42331613 | PubTator, text mining | PubMed |
| Generation of two LGMDR4 patients derived induced pluripotent stem cell line carrying the SGCB frameshift mutation (p.Gly129_Arg130insGlnTer). | Stem Cell Res | 2026 | 42225003 | PubTator, text mining | PubMed |
| Homozygous SGCB splice-site variant causes isolated dilated cardiomyopathy through sarcoglycan complex destabilization in East Asians. | J Clin Invest | 2026 | 42222889 | PubTator, text mining | PubMed |
| MicroRNA-155 at the crossroads of inflammation and vascular dysfunction in essential hypertension. | Mol Biol Rep | 2026 | 42216994 | PubTator, text mining | PubMed |
1 to 10 of 1,640
See all 1,640 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6443
GET https://conductscience.org/api/genes/v1/6443/patents?page=2